Biblio

Export 791 results:
[ Author(Desc)] Title Type Year
Filters: Keyword is Humans  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
W. Vendramini Borelli, Augustin, M. Coutinho, de Oliveira, P. Bell Felix, Reggiani, L. Casagrande, Bandeira-de-Mello, R. Gorga, Schumacher-Schuh, A. Francisco, Chaves, M. Lorena Fag, and Castilhos, R. Machado, Neuropsychiatric Symptoms in Patients with Dementia Associated with Increased Psychological Distress in Caregivers During the COVID-19 Pandemic., J Alzheimers Dis, vol. 80, no. 4, pp. 1705-1712, 2021.
G. Boström, Freyhult, E., Virhammar, J., Alcolea, D., Tumani, H., Otto, M., Brundin, R. - M., Kilander, L., Löwenmark, M., Giedraitis, V., Lleo, A., von Arnim, C. A. F., Kultima, K., and Ingelsson, M., Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid., J Alzheimers Dis, vol. 81, no. 2, pp. 629-640, 2021.
B. O. A. Botchway, Moore, M. K., Akinleye, F. O., Iyer, I. C., and Fang, M., Nutrition: Review on the Possible Treatment for Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 3, pp. 867-883, 2018.
A. Boulares, Fabre, C., Cherni, A., Jdidi, H., Chortane, S. Gaied, Trompetto, C., Puce, L., and Bragazzi, N. Luigi, Effects of a Physical Activity Program that Incorporates Exercises Targeting Balance, Strength, and Proprioception on Cognitive Functions and Physical Performance in Old Adults with Mild Cognitive Impairment., J Alzheimers Dis, vol. 96, no. 1, pp. 245-260, 2023.
K. Bourgade, Le Page, A., Bocti, C., Witkowski, J. M., Dupuis, G., Frost, E. H., and Fülöp, T., Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model., J Alzheimers Dis, vol. 50, no. 4, pp. 1227-41, 2016.
O. Bousiges, Cretin, B., Lavaux, T., Philippi, N., Jung, B., Hezard, S., Heitz, C., Demuynck, C., Gabel, A., Martin-Hunyadi, C., and Blanc, F., Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies., J Alzheimers Dis, vol. 51, no. 4, pp. 1069-83, 2016.
C. Boutoleau-Bretonnière, Pouclet-Courtemanche, H., Gillet, A., Bernard, A., Deruet, A. Laure, Gouraud, I., Mazoue, A., Lamy, E., Rocher, L., Kapogiannis, D., and Haj, M. El, The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis., J Alzheimers Dis, vol. 76, no. 1, pp. 41-47, 2020.
W. H. Bouvy, Kuijf, H. J., Zwanenburg, J. J. M., Koek, H. L., L Kappelle, J., Luijten, P. R., M Ikram, K., and Biessels, G. Jan, Abnormalities of Cerebral Deep Medullary Veins on 7 Tesla MRI in Amnestic Mild Cognitive Impairment and Early Alzheimer's Disease: A Pilot Study., J Alzheimers Dis, vol. 57, no. 3, pp. 705-710, 2017.
H. Braak, Thal, D. R., Ghebremedhin, E., and Del Tredici, K., Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years., J Neuropathol Exp Neurol, vol. 70, no. 11, pp. 960-9, 2011.
D. E. Bredesen, Toups, K., Hathaway, A., Gordon, D., Chung, H., Raji, C., Boyd, A., Hill, B. D., Hausman-Cohen, S., Attarha, M., Chwa, W. Jong, Kurakin, A., and Jarrett, M., Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications., J Alzheimers Dis, vol. 96, no. 2, pp. 429-437, 2023.
D. Brici, Götz, J., and Nisbet, R. M., A Novel Antibody Targeting Tau Phosphorylated at Serine 235 Detects Neurofibrillary Tangles., J Alzheimers Dis, vol. 61, no. 3, pp. 899-905, 2018.
P. Buchhave, Minthon, L., Zetterberg, H., Wallin, A. K., Blennow, K., and Hansson, O., Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia., Arch Gen Psychiatry, vol. 69, no. 1, pp. 98-106, 2012.
A. S. Bukhbinder, Ling, Y., Hasan, O., Jiang, X., Kim, Y., Phelps, K. N., Schmandt, R. E., Amran, A., Coburn, R., Ramesh, S., Xiao, Q., and Schulz, P. E., Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching., J Alzheimers Dis, vol. 88, no. 3, pp. 1061-1074, 2022.
M. A. Burguillos, Deierborg, T., Kavanagh, E., Persson, A., Hajji, N., Garcia-Quintanilla, A., Cano, J., Brundin, P., Englund, E., Venero, J. L., and Joseph, B., Caspase signalling controls microglia activation and neurotoxicity., Nature, vol. 472, no. 7343, pp. 319-24, 2011.
C. M. Burns, Kaszniak, A. W., Chen, K., Lee, W., Bandy, D. J., Caselli, R. J., and Reiman, E. M., Longitudinal Changes in Serum Glucose Levels are Associated with Metabolic Changes in Alzheimer's Disease Related Brain Regions., J Alzheimers Dis, vol. 62, no. 2, pp. 833-840, 2018.
J. R. Burrell, Ballard, K. J., Halliday, G. M., and Hodges, J. R., Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia., J Alzheimers Dis, vol. 61, no. 2, pp. 705-715, 2018.
C
P. Caffarra, Ghetti, C., Ruffini, L., Spallazzi, M., Spotti, A., Barocco, F., Guzzo, C., Marchi, M., and Gardini, S., Brain Metabolism Correlates of the Free and Cued Selective Reminding Test in Mild Cognitive Impairment., J Alzheimers Dis, vol. 51, no. 1, pp. 27-31, 2016.
L. Calderón-Garcidueñas, Torres-Jardón, R., Franco-Lira, M., Kulesza, R., González-Maciel, A., Reynoso-Robles, R., Brito-Aguilar, R., García-Arreola, B., Revueltas-Ficachi, P., Barrera-Velázquez, J. Adriana, García-Alonso, G., García-Rojas, E., Mukherjee, P. S., and Delgado-Chávez, R., Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution., J Alzheimers Dis, vol. 78, no. 2, pp. 479-503, 2020.
L. Calderón-Garcidueñas, Kavanaugh, M., Block, M., D'Angiulli, A., Delgado-Chávez, R., Torres-Jardón, R., González-Maciel, A., Reynoso-Robles, R., Osnaya, N., Villarreal-Calderon, R., Guo, R., Hua, Z., Zhu, H., Perry, G., and Diaz, P., Neuroinflammation, hyperphosphorylated tau, diffuse amyloid plaques, and down-regulation of the cellular prion protein in air pollution exposed children and young adults., J Alzheimers Dis, vol. 28, no. 1, pp. 93-107, 2012.
X. Cao, Zhu, M., He, Y., Chu, W., Du, Y., and Du, H., Increased Serum Acylated Ghrelin Levels in Patients with Mild Cognitive Impairment., J Alzheimers Dis, vol. 61, no. 2, pp. 545-552, 2018.
R. Capozzo, Zoccolella, S., Frisullo, M. Elisa, Barone, R., Dell'Abate, M. Teresa, Barulli, M. Rosaria, Musio, M., Accogli, M., and Logroscino, G., Telemedicine for Delivery of Care in Frontotemporal Lobar Degeneration During COVID-19 Pandemic: Results from Southern Italy., J Alzheimers Dis, vol. 76, no. 2, pp. 481-489, 2020.
N. Carcavilla, Pozo, A. Sofía, González, B., Moral-Cuesta, D., Roldán, J. Joaquín, Erice, V., and Remírez, Ade Ganuza, Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic., J Alzheimers Dis, vol. 80, no. 2, pp. 533-537, 2021.
M. Carmona-Iragui, Fernández-Arcos, A., Alcolea, D., Piazza, F., Morenas-Rodriguez, E., Antón-Aguirre, S., Sala, I., Clarimón, J., Dols-Icardo, O., Camacho, V., Sampedro, F., Munuera, J., Nuñez-Marin, F., Lleo, A., Fortea, J., Gómez-Ansón, B., and Blesa, R., Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation., J Alzheimers Dis, vol. 50, no. 1, pp. 1-7, 2016.
J. M. Castellano, Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., Goate, A. M., Bales, K. R., Paul, S. M., Bateman, R. J., and Holtzman, D. M., Human apoE isoforms differentially regulate brain amyloid-β peptide clearance., Sci Transl Med, vol. 3, no. 89, p. 89ra57, 2011.
Y. Ling Chai, Xing, H., Chong, J. R., Francis, P. T., Ballard, C. G., Chen, C. P., and Lai, M. K. P., Mitochondrial Translocase of the Outer Membrane Alterations May Underlie Dysfunctional Oxidative Phosphorylation in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 793-801, 2018.

Pages